Application 065315
- Type
- ANDA
- Sponsor
- VINTAGE
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | NYSTATIN | NYSTATIN | CREAM;TOPICAL | 100,000 UNITS/GM | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A065315-001 | NYSTATIN | NYSTATIN | 100,000 UNITS/GM | CREAM / TOPICAL | 2006-05-31 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A065315-001 | NYSTATIN | 100,000 UNITS/GM | CREAM / TOPICAL | 2006-05-31 | 3a93d1ddd44b… | ||
| 2022-10-28 04:53 UTC | 2022-10 | A065315-001 | NYSTATIN | 100,000 UNITS/GM | CREAM / TOPICAL | 2006-05-31 | f41ea6bd6efb… | ||
| 2022-09-29 23:25 UTC | 2022-09 | A065315-001 | NYSTATIN | 100,000 UNITS/GM | CREAM / TOPICAL | 2006-05-31 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A065315-001 | NYSTATIN | 100,000 UNITS/GM | CREAM / TOPICAL | 2006-05-31 | cb3db0bc1861… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A065315-001 | NYSTATIN | 100,000 UNITS/GM | CREAM / TOPICAL | 2006-05-31 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | A065315-001 | AT | 1 | 74a2ff9319b5… |
| 2019-12-14 00:12 UTC | 2019-12 | A065315-001 | AT | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A065315-001 | AT | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A065315-001 | AT | 1 | ea99ee380514… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Nystatin | NYSTATIN | Cardinal Health 107, LLC | 56aca0e2-8691-4701-beba-e2315524709f | 2026-10-27 | Adverse reactions | Nystatin NYSTATIN |
| Nystatin | NYSTATIN CREAM | Redpharm Drug | 5e56fa99-3244-0b7b-e063-6394a90af4a1 | 2026-10-21 | Adverse reactions | Nystatin |
| Nystatin | NYSTATIN | Cardinal Health 107, LLC | d59098da-1395-49fb-9fd6-947bbbeed56f | 2026-10-12 | Adverse reactions | Nystatin NYSTATIN |
| NYSTATIN | NYSTATIN | Preferred Pharmaceuticals Inc. | 8211a0ef-98a8-4136-986c-23c306db1159 | 2026-10-09 | Adverse reactions | NYSTATIN NYSTATIN |
| NYSTATIN | NYSTATIN | Kanchan Healthcare Inc | 90a52c3f-3ef7-4f3b-9fe5-40af408e9f2a | 2026-10-07 | Adverse reactions | NYSTATIN NYSTATIN |
| nystatin | NYSTATIN | NuCare Pharmaceuticals,Inc. | 05cc72dd-8e05-bfb5-e063-6394a90a92f1 | 2026-08-19 | Adverse reactions | nystatin NYSTATIN |
| nystatin | NYSTATIN | Preferred Pharmaceuticals Inc. | 197e3046-3e58-4246-b260-f3995dce41a1 | 2026-08-05 | Adverse reactions | nystatin NYSTATIN |
| Nystatin | NYSTATIN | Preferred Pharmaceuticals Inc. | d92f67a7-dcae-41c0-9a35-dbafa2361170 | 2026-08-04 | Adverse reactions | Nystatin NYSTATIN |
| Nystatin | NYSTATIN | A-S Medication Solutions | 98bd8ccb-0c68-47b9-bcb4-c5d8217868d9 | 2026-07-24 | Adverse reactions | Nystatin NYSTATIN |
| Nystatin | NYSTATIN | PAI Holdings, LLC dba PAI Pharma | 28b4e26e-206a-4e8a-abfe-774b780e91c3 | 2026-07-21 | Adverse reactions | Nystatin NYSTATIN |
| Nystop | NYSTATIN | Bryant Ranch Prepack | 0bb31239-fb77-442a-a9ee-ba61b45e7e68 | 2026-07-14 | Adverse reactions | NYSTATIN |
| Nystatin | NYSTATIN | Bryant Ranch Prepack | 2d2c4f79-95b5-417e-b5c1-8fac1dd09ddc | 2026-07-09 | Adverse reactions | Nystatin NYSTATIN |
| Nystatin | NYSTATIN | Preferred Pharmaceuticals Inc. | a97b4fa6-c1a7-4003-9321-3717eb640ea9 | 2026-07-06 | Adverse reactions | Nystatin NYSTATIN |
| NYSTATIN | NYSTATIN | Kesin Pharma Corporation | 50737729-a4a4-e747-e063-6394a90adcc5 | 2026-06-30 | Adverse reactions | NYSTATIN NYSTATIN |
| NYSTATIN | NYSTATIN | Bryant Ranch Prepack | 4f6f59fb-ae7d-48e5-b23e-a1d92160974f | 2026-05-11 | Adverse reactions | NYSTATIN NYSTATIN |
| Nystatin | NYSTATIN | Torrent Pharmaceuticals Limited | 4949dea7-d2b9-4e0d-974a-39408fa174ba | 2026-05-08 | Adverse reactions | Nystatin NYSTATIN |
| NYSTATIN | NYSTATIN | Genus Lifesciences Inc. | b25cbae5-eaf5-4501-b013-02c778ca4a4e | 2026-05-07 | Adverse reactions | NYSTATIN NYSTATIN |
| Nystatin | NYSTATIN | Torrent Pharmaceuticals Limited | 559b5bd4-3564-4437-8d0a-fa3a972f8b83 | 2026-05-01 | Adverse reactions | Nystatin NYSTATIN |
| Mycostatin | NYSTATIN | Direct_Rx | f1857ac0-806c-4a7e-e053-2995a90abbc0 | 2026-03-17 | Adverse reactions | NYSTATIN |
| Nystatin | NYSTATIN | A-S Medication Solutions | f1b13a36-c349-4e26-a322-3ec02c610155 | 2026-03-16 | Adverse reactions | Nystatin NYSTATIN |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0603-7818 | Nystatin | nystatin | Par Pharmaceutical | ANDA | Current |
| 0603-7818 | Nystatin | nystatin | Par Pharmaceutical | ANDA | Current |
| 50090-0241 | Nystatin | nystatin | A-S Medication Solutions | ANDA | Current |
| 50090-0245 | Nystatin | nystatin | A-S Medication Solutions | ANDA | Current |
| 68258-3046 | Nystatin | nystatin | Dispensing Solutions, Inc. | ANDA | Current |
| 68788-0178 | Nystatin | nystatin | Preferred Pharmaceuticals, Inc. | ANDA | Current |